简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-04-30 14:09 SINOVAC Announces Record and Distribution Dates for Special Cash Dividend
2025-04-29 17:12 SINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo Capital
2025-04-29 17:06 Actus Nutrition Acquires Protein Facility from Foremost Farms USA
2025-04-29 16:44 Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets
2025-04-29 10:22 HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials
2025-04-29 10:17 Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine
2025-04-28 15:13 CN Bio and Pharmaron Establish Long-Term Strategic Partnership to Develop OOC Technologies on a Global R&D Platform
2025-04-27 12:34 Erbe introduces VIO® 3n & VIO® seal: Tailored electrosurgical generators for high-performance workflows
2025-04-25 15:42 UPS to Acquire Andlauer Healthcare Group for $1.6 Billion, Strengthening its Global Offerings in Complex Healthcare Logistics
2025-04-25 11:57 PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
2025-04-24 16:33 Pacific Prime Wins Now Health’s Best Business Partner 2024-2025
2025-04-24 15:32 QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, Wound Healing, and Psoriasis
2025-04-24 14:26 Galderma Delivers Record First Quarter Net Sales of 1.129 Billion USD, Including Strong Performance From Two Launches With Blockbuster Potential, and Confirms Full-Year Guidance
2025-04-24 10:17 Grant Award from GHIT Fund for Development of an Ultrasensitive Urine Test for Tuberculosis
2025-04-23 16:15 Global Health Experts Appointed to Judge Aster Guardians Global Nursing Award 2025, to Be Held in Dubai
2025-04-23 09:32 Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay
2025-04-22 16:16 A new weapon in the global fight against malaria
2025-04-22 09:17 Ferring Announces Initial Data from Phase 3 Trial in Japanese Patients Demonstrating 75% Complete Response Rate at 3 Months with (nadofaragene firadenovec) in BCG-unresponsive NMIBC Patients1
2025-04-22 09:12 Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary Fibrosis Trials with Release of Global Market Insights
2025-04-18 16:36 Rigaku and SPERA PHARMA Initiate Strategic Partnership to Advanced Pharmaceutical Development